96,433 Shares in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Purchased by BNP Paribas Financial Markets
BNP Paribas Financial Markets acquired a new position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 96,433 shares of the company’s stock, valued at approximately $323,000. Several other institutional investors also recently bought and sold shares […]
BNP Paribas Financial Markets acquired a new position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 96,433 shares of the company’s stock, valued at approximately $323,000. Several other institutional investors also recently bought and sold shares […]
